These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24097424)

  • 1. Lipid-lowering drugs associated with slower motor decline in the elderly adults.
    Dumurgier J; Singh-Manoux A; Tavernier B; Tzourio C; Elbaz A
    J Gerontol A Biol Sci Med Sci; 2014 Feb; 69(2):199-206. PubMed ID: 24097424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decline in Fast Gait Speed as a Predictor of Disability in Older Adults.
    Artaud F; Singh-Manoux A; Dugravot A; Tzourio C; Elbaz A
    J Am Geriatr Soc; 2015 Jun; 63(6):1129-36. PubMed ID: 26096387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Therapy and Risk of Acute Memory Impairment.
    Strom BL; Schinnar R; Karlawish J; Hennessy S; Teal V; Bilker WB
    JAMA Intern Med; 2015 Aug; 175(8):1399-405. PubMed ID: 26054031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do lipids and apolipoproteins predict coronary heart disease under statin and fibrate therapy in the primary prevention setting in community-dwelling elderly subjects? The 3C Study.
    Straczek C; Tafflet M; Barberger-Gateau P; Bertrand M; Dupuy AM; Ducimetière P; Empana JP
    Atherosclerosis; 2011 Feb; 214(2):426-31. PubMed ID: 21129746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in fast walking speed preceding death: results from a prospective longitudinal cohort study.
    Sabia S; Dumurgier J; Tavernier B; Head J; Tzourio C; Elbaz A
    J Gerontol A Biol Sci Med Sci; 2014 Mar; 69(3):354-62. PubMed ID: 23913931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index trajectories and functional decline in older adults: Three-City Dijon cohort study.
    Artaud F; Singh-Manoux A; Dugravot A; Tavernier B; Tzourio C; Elbaz A
    Eur J Epidemiol; 2016 Jan; 31(1):73-83. PubMed ID: 25855001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid lowering agents, cognitive decline, and dementia: the three-city study.
    Ancelin ML; Carrière I; Barberger-Gateau P; Auriacombe S; Rouaud O; Fourlanos S; Berr C; Dupuy AM; Ritchie K
    J Alzheimers Dis; 2012; 30(3):629-37. PubMed ID: 22451317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study.
    Sidell MA; Ghai NR; Reynolds K; Jacobsen SJ; Scott R; Van Den Eeden S; Caan B; Quinn VP
    Prev Med; 2019 Dec; 129():105822. PubMed ID: 31470024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of statin treatment alone and in combination with fibrates in patients with dyslipidemia: a meta-analysis.
    Choi HD; Shin WG
    Curr Med Res Opin; 2014 Jan; 30(1):1-10. PubMed ID: 24063624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipid parameters, lipid lowering drugs and the risk of venous thromboembolism.
    Delluc A; Malécot JM; Kerspern H; Nowak E; Carre JL; Mottier D; Le Gal G; Lacut K
    Atherosclerosis; 2012 Jan; 220(1):184-8. PubMed ID: 22035572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study.
    Alpérovitch A; Kurth T; Bertrand M; Ancelin ML; Helmer C; Debette S; Tzourio C
    BMJ; 2015 May; 350():h2335. PubMed ID: 25989805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Statins or Fibrates for the Primary Prevention of Stroke in the Elderly. Faith Makes Some Things Achievable, But Not AII.
    Athyros VG; Tziomalos K; Karagiannis A
    Curr Vasc Pharmacol; 2015; 13(6):696-8. PubMed ID: 26459809
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrates and niacin: is there a place for them in clinical practice?
    Wierzbicki AS; Viljoen A
    Expert Opin Pharmacother; 2014 Dec; 15(18):2673-80. PubMed ID: 25318657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Motor function in the elderly: evidence for the reserve hypothesis.
    Elbaz A; Vicente-Vytopilova P; Tavernier B; Sabia S; Dumurgier J; Mazoyer B; Singh-Manoux A; Tzourio C
    Neurology; 2013 Jul; 81(5):417-26. PubMed ID: 23803317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who receives lipid-lowering drugs: the effects of comorbidities and patient characteristics on treatment initiation.
    Yang CC; Jick SS; Testa MA
    Br J Clin Pharmacol; 2003 Mar; 55(3):288-98. PubMed ID: 12630980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of Fibrates Monotherapy in People with Diabetes and High Cardiovascular Risk in Primary Care: A French Nationwide Cohort Study Based on National Administrative Databases.
    Roussel R; Chaignot C; Weill A; Travert F; Hansel B; Marre M; Ricordeau P; Alla F; Allemand H
    PLoS One; 2015; 10(9):e0137733. PubMed ID: 26398765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-Lowering Agents in Older Individuals: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Ponce OJ; Larrea-Mantilla L; Hemmingsen B; Serrano V; Rodriguez-Gutierrez R; Spencer-Bonilla G; Alvarez-Villalobos N; Benkhadra K; Haddad A; Gionfriddo MR; Prokop LJ; Brito JP; Murad MH
    J Clin Endocrinol Metab; 2019 May; 104(5):1585-1594. PubMed ID: 30903687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statin use and decline in gait speed in community-dwelling older adults.
    Lo-Ciganic WH; Perera S; Gray SL; Boudreau RM; Zgibor JC; Strotmeyer ES; Donohue JM; Bunker CH; Newman AB; Simonsick EM; Bauer DC; Satterfield S; Caserotti P; Harris T; Shorr RI; Hanlon JT;
    J Am Geriatr Soc; 2015 Jan; 63(1):124-9. PubMed ID: 25537649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Lipid Lowering Drugs on Arterial Stiffness: One More Way to Reduce Cardiovascular Risk?
    Reklou A; Katsiki N; Karagiannis A; Athyros V
    Curr Vasc Pharmacol; 2020; 18(1):38-42. PubMed ID: 30663570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
    Reiner Z
    Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.